30JPY
1.00 BJPY
12.52 BJPY
9.17 M
About LINICAL CO LTD
Sector
Headquarters
Osaka
Website
Employees (FY)
759
Founded
2005
ISIN
JP3974530002
FIGI
BBG000J4YN11
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) and Pharmaceutical business segments. The CRO business segment provides outsourced pharmaceutical development services. The Pharmaceutical business segment handles marketing support on products of the pharmaceutical companies. The company was founded by Kazuhiro Hatano on June 7, 2005 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2183 is 390 JPY — it has decreased by 2.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange LINICAL CO LTD stocks are traded under the ticker 2183.
LINICAL CO LTD is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
2183 stock is 2.31% volatile and has beta coefficient of 0.59. Check out the list of the most volatile stocks — is LINICAL CO LTD there?
One year price forecast for LINICAL CO LTD has a max estimate of 500 JPY and a min estimate of 500 JPY.
LINICAL CO LTD revenue for the last quarter amounts to 2.98 B JPY despite the estimated figure of 3.21 B JPY. In the next quarter revenue is expected to reach 3.44 B JPY.
Yes, you can track LINICAL CO LTD financials in yearly and quarterly reports right on TradingView.
2183 stock hasn't changed in a week, the month change is a 2.50% fall, over the last year LINICAL CO LTD has showed a 45.15% decrease.
2183 net income for the last quarter is 74.64 M JPY, while the quarter before that showed 175.37 M JPY of net income which accounts for −57.44% change. Track more LINICAL CO LTD financial stats to get the full picture.
Today LINICAL CO LTD has the market capitalization of 9.01 B, it has decreased by 0.52% over the last week.
LINICAL CO LTD dividend yield was 2.01% in 2022, and payout ratio reached 31.48%. The year before the numbers were 1.53% and 40.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 2183 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LINICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 759.00 employees. See our rating of the largest employees — is LINICAL CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LINICAL CO LTD technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LINICAL CO LTD stock shows the sell signal. See more of LINICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LINICAL CO LTD future price: according to them, 2183 price has a max estimate of 500.00 JPY and a min estimate of 500.00 JPY. Read a more detailed LINICAL CO LTD forecast: see what analysts think of LINICAL CO LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LINICAL CO LTD EBITDA is 1.66 B JPY, and current EBITDA margin is 14.06%. See more stats in LINICAL CO LTD financial statements.